News
Alex to present at the world's largest cancer conference
A/ Prof. Alex van Akkooi receives prestigious NHMRC grant to lead practice changing surgical trial.
A/ Prof. Alex van Akkooi receives prestigious NHMRC grant to lead practice changing surgical trial.
A/Prof. Dr. Alexander van Akkooi will present at the prestigious Annual Meeting of the American Society of Clinical Oncology (ASCO), in Chicago, IL, USA on the primary results of the EORTC 2139 - Columbus AD trial.
A study that looked at adjuvant BRAF/MEK inhibition after surgical removal for stage IIB/C Melanoma to reduce disease recurrence.
A/ Prof. Alex van Akkooi receives prestigious NHMRC grant to lead practice changing surgical trial.
A/ Prof. Alex van Akkooi receives prestigious NHMRC grant to lead practice changing surgical trial.
A/ Prof. Alex van Akkooi receives prestigious NHMRC grant to lead practice changing surgical trial.
A/Prof. Dr. Alexander van Akkooi has been awarded a highly competitive National Health and Medical Research Council (NHMRC) grant to lead an international clinical trial aiming to safely reduce surgery for high risk stage III melanoma patients who have had a good response to neoadjuvant immunotherapy.
Affiliated with
Proud Member of
